# Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System

Study · id `cardio:ct-nct03102437` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03102437](<https://clinicaltrials.gov/study/NCT03102437>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03102437

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 106 participants.

## Technical summary

Registry record NCT03102437. Allocation not applicable; no masking; primary purpose treatment. Start 2017-07-01 (actual); primary completion 2019-12-16 (actual). Results posted on 2021-11-23.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 106 participants (enrolled count; ClinicalTrials.gov record NCT03102437, source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)
- Started: 2017-07-01 (actual) (ClinicalTrials.gov record NCT03102437, source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)
- Primary completion: 2019-12-16 (actual) (ClinicalTrials.gov record NCT03102437, source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)
- Completion: 2019-12-16 (actual) (ClinicalTrials.gov record NCT03102437, source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)
- Results first posted: 2021-11-23 (ClinicalTrials.gov record NCT03102437, source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03102437, source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03102437-2021-11-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
- Acronym: FIX-HF-5CA
- Condition: Heart Failure
- Condition: Congestive Heart Failure
- Condition: Chronic Heart Disease
- Condition: CHF
- Intervention (Device): Optimizer Smart System
- Lead sponsor: Impulse Dynamics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Impulse Dynamics (`cardio:org-impulse-dynamics`)

## Provenance

Content hash: dbc3f8833f150cc9d0d2a5f7bb102d1805a8a7d0b21db9e3c2da051e1d12a021
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
